title: [Diagnosis and treatment of aspergillosis in the patients with chronic granulomatous disease].
abstract: Chronic granulomatous disease is a rare defect of phagocytosis. Increased susceptibility to infections is limited to catalase positive bacteria and fungi. Aspergillus spp was reported as the increased clinical problem and the main cause of the deaths.
authors.affiliation: Oddział Immunologii, Klinika Gastroenterologii, Hepatologii i Immunologii, Instytut Pomnik-Centrum Zdrowia Dziecka. immuno@czd.waw.pl
authors.forename: Magdalena
authors.initials: M
authors.lastname: Kurenko-Deptuch
authors.forename: Beata
authors.initials: B
authors.lastname: Wolska-Kuśnierz
authors.forename: Edyta
authors.initials: E
authors.lastname: Heropolitańska-Pliszka
authors.forename: Maja
authors.initials: M
authors.lastname: Klaudel-Dreszler
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Pac
authors.forename: Barbara
authors.initials: B
authors.lastname: Pietrucha
authors.forename: Barbara
authors.initials: B
authors.lastname: Garczewska
authors.forename: Ewa
authors.initials: E
authors.lastname: Bernatowska
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D001233:Aspergillus nidulans / Q000302:isolation & purification; D002648:Child; D004797:Enzyme-Linked Immunosorbent Assay; D006105:Granulomatous Disease, Chronic / Q000150:complications* / Q000382:microbiology; D006801:Humans; D016133:Polymerase Chain Reaction
chemical_list: D000935:Antifungal Agents